Bio-Works
Private Company
Total funding raised: $55.5M
Overview
Bio-Works is a specialized provider of chromatography purification solutions, serving the global biopharmaceutical industry from its base in Uppsala, Sweden. The company leverages deep expertise in agarose resin technology to produce its flagship WorkBeads™ resins and GoBio™ pre-packed columns, which are critical for downstream processing in drug manufacturing. With a certified ISO 9001 quality system and a strong customer support focus, Bio-Works has established itself as a trusted partner, with its products cited in numerous industry publications and used in the purification of over 15 commercial drugs. The company operates as a private, revenue-generating business-to-business supplier within the biologics manufacturing value chain.
Technology Platform
Proprietary agarose-based chromatography resin platform (WorkBeads™) featuring beads with tight bead- and pore-size distribution for high purity, binding capacity, and flow rates in biomolecule purification.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Bio-Works competes in the chromatography resin market against large, diversified life science tools giants such as Cytiva (Danaher), Thermo Fisher Scientific, and Merck KGaA. Its competitive strategy is based on differentiation through superior product performance (tight bead-size distribution), deep technical expertise in agarose chemistry, and a strong focus on customer support and partnership, rather than competing solely on scale or price.